Foundation Medicine, Ophthotech Enjoy First-Day IPO Pops
This article was originally published in The Pink Sheet Daily
Executive Summary
The flood of new listings continued unabated, as a trio of offerings followed three successful IPOs last week. Cancer diagnostics start-up Foundation Medicine and “wet” AMD therapy developer Ophthotech outperformed expectations, pricing above their ranges and selling more shares than anticipated.